Motiva Flora Tissue Expander Debuts in the U.S.
Establishment Labs Holdings Inc. announces the first-ever utilization of the Motiva Flora SmoothSilk Tissue Expander in the United States, following its recent FDA clearance.
Establishment Labs Holdings Inc. announces the first-ever utilization of the Motiva Flora SmoothSilk Tissue Expander in the United States, following its recent FDA clearance.
The American Academy of Dermatology issued four strong evidence-based recommendations for the treatment of atopic dermatitis in adults in its 2025 focused update.